Article

Segment 8 - Financial Incentives and Penalties

Panelists analyzed the concept of penalizing providers who deviate from pathway programs.

Panelists analyzed the concept of penalizing providers who deviate from pathway programs.

Dr Malin said rather than having a penalty, WellPoint chooses to incentivize behavior. When providers select treatments that are “off pathway,” they are reimbursed, but there are additional financial incentives for providers who select treatments that are “on pathway.”

Dr Yu agreed that incentives to change are preferable to penalties. He added that payers should not seek to penalize either— incentives should be determined internally from institutions or at the provider-group level.

Dr Nabhan said that by not achieving a certain pathway metric, a provider technically “penalizes” him or herself by missing the potential financial incentives that are available to them.

Related Videos
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
dr joseph alvarnas
Screenshot of an interview with A. Mark Fendrick, MD
Screenshot of Scott Soefje, PharmD, BCOP, during  a video interview with. the AJMCtv logo in the top corner
Steve Pickette, PharmD
dr alex jahangir
dr katherine baker
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo